Revelation Biosciences Inc (REVB) — Cash Flow Reinvestment Rate
Revelation Biosciences Inc (REVB) has a Cash Flow Reinvestment Rate of 2.22x as of December 2018, reinvesting $18.70 Million (capex $349.00K plus investments $-18.35 Million) from operating cash flow of $8.43 Million. Explore REVB capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Revelation Biosciences Inc Cash Flow Reinvestment Rate (2015–2019)
Historical reinvestment intensity for Revelation Biosciences Inc across 5 annual periods. Also explore Revelation Biosciences Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Revelation Biosciences Inc (2015–2019)
Year-by-year capital reinvestment analysis for Revelation Biosciences Inc. For live market cap and broader valuation context, see Revelation Biosciences Inc (REVB) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 8.98x | $369.13 Million | $41.09 Million | $526.00K | ▼ -1.0% |
| 2018 | 9.08x | $295.71 Million | $32.58 Million | $861.00K | ▼ -12.8% |
| 2017 | 10.41x | $252.40 Million | $24.25 Million | $804.00K | ▼ -38.8% |
| 2016 | 17.01x | $197.25 Million | $11.60 Million | $582.00K | ▲ +511.2% |
| 2015 | 2.78x | $32.27 Million | $11.60 Million | $582.00K | — |